A carregar...
Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review
OBJECTIVES: To examine the evidence derived from randomized controlled clinical trials on the efficacy and safety of omalizumab compared to placebo in controlling symptoms of chronic idiopathic urticaria/chronic spontaneous urticaria (CIU/CSU). DATA SOURCE: The electronic databases PubMed, Medline,...
Na minha lista:
| Publicado no: | World Allergy Organ J |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4280746/ https://ncbi.nlm.nih.gov/pubmed/25566332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40413-014-0050-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|